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The coronavirus disease (COVID-19) caused by the severe acute 
respiratory syndrome coronavirus (SARS-CoV-2) rapidly became a 
public health emergency of international concern requiring urgent 
attention. It emerged late in 2019 in China as a respiratory pathogen, 
with the first epicentres observed in Iran, Spain and northern Italy. 
At the time of writing there were about 4 525 497 cases and 307 395 
deaths worldwide, of which 1 409 452 cases and 85 860 deaths were 
in the USA, which is the most affected country in absolute terms.[1] 
The COVID-19 pandemic has been marked by extreme heterogeneity 
in both geography and population across the world. Consequently, 
leveraging local data aligned to the unique South African (SA) context 
is critical. Moreover, comprehensive mathematical models should 
integrate the full complexity of transmission dynamics observed with 
COVID-19 in the context of rapidly changing individual, social and 
structural determinants in SA.
From the diagnosis of the first case of SARS-CoV-2 in SA on 
5 March 2020 to 16 May, there were 14 355 confirmed cases and 
261 deaths.[2,3] However, the COVID-19-specific surveillance data 
employed since March are still severely restricted. The data vary 
by province and are preliminary, incomplete and not generalisable, 
with severe restrictions on numbers of available test kits and 
laboratory capacity. By the time sufficient data are collected and 
analysed, opportunities for epidemic mitigation may have been 
lost. Preliminary COVID-19 surveillance data can be strengthened 
through utilisation of past pandemic data on respiratory pathogens to 
inform the structure and parameters of current mathematical models 
and for sustained public health response. We therefore compared 
the transmission dynamics of SARS-CoV-2 with the lipid-enveloped 
H1N1 virus called A(H1N1)pdm09 that caused a pandemic resulting 
in ~575 400 deaths globally in 2009.[4] In the USA, where it began, 
the novel A(H1N1)pdm09 virus resulted in 60.8 million cases, 
274 304 hospitalisations and 12 469 deaths from 12 April 2009 
to 10 April 2010.[4] In SA, the A(H1N1)pdm09 virus resulted in 
12  331 confirmed cases and 91 deaths from 14 July to 12 October 
2009.[5] Recent influenza pandemic proportions of cases in SA have 
been interestingly low compared with other parts of the world. 
The population-level morbidity and mortality related to A(H1N1)
pdm09 was notably much lower in SA compared with countries in 
the Northern Hemisphere generally. [4] This heterogeneity is also 
evident in preliminary COVID-19 incidence and mortality data. 
Although there have been other severe viral epidemics in SA, we 
confined assessment of the past pandemic transmission dynamics to 
the most recent influenza pandemic, the 2009 A(H1N1)pdm09, given 
contextual similarities with COVID-19 in terms of availability of 
surveillance systems, and medical, technological and social advances.
Although the novel coronavirus is new to the immune systems 
of humans, similarities with the novel A(H1N1)pdm09 virus were 
found. In an analysis of the first 100 deaths from A(H1N1)pdm09, 
most fatalities in SA were in the more affluent population and 
linked to travel.[6] Similarly, the COVID-19 virus first emerged 
among affluent people who had either travelled internationally 
or been exposed to individuals who had done so.[7] The greatest 
burden of A(H1N1)pdm09 cases was in the three provinces with 
the largest metropolitan areas, namely Gauteng, Western Cape and 
KwaZulu-Natal.[5] Similarly, the highest numbers of cases of COVID-
19 to date have been in the same three provinces, with 8 404 cases, 
representing 58.5% of the country’s total, in the Western Cape.[2] The 
latter is attributed to population density, access to healthcare, and 
testing and tracing strategies. In both A(H1N1)pdm09 and COVID-
19, the growth in numbers of cases rapidly transitioned to lower 
socioeconomic groups owing to challenges related to self-isolation 
and social distancing in overcrowded settings; lack of affordability 
of hygiene products; lack of access to potable water and proper 
sanitation; and food insecurity.[2,6] These extreme socioeconomic 
disparities threaten the survival of vulnerable communities and 
have serious implications for estimating the potential impact of 
COVID-19. The incidence of A(H1N1)pdm09 infections declined 
significantly during the transition from winter to spring in SA, 
suggesting that winter, which is the typical season for influenza, 
may have been conducive to spread of the A(H1N1)pdm09 virus. [5] 
Similarly, the colder temperatures in winter may be conducive to 
spread of the SARS-CoV-2 virus, as is the case for seasonal influenza. 
As SA enters its influenza season, it is critical for surveillance 
strategies to evaluate the possible shared risks for both COVID-19 
and seasonal influenza, as co-infections could potentially increase 
disease severity and mortality.
Co-infections with HIV and tuberculosis (TB) during the 2009 
A(H1N1)pdm09 epidemic in SA were associated with disease 
severity and death. The A(H1N1)pdm09 virus mostly killed young 
adults in SA, with a median age of 33.5 years.[5] Fatalities among 
these young adults were related to TB, HIV, being pregnant, and 
pre-existing metabolic conditions.[5] Although the associations with 
HIV and TB are not yet clear in the preliminary COVID-19 data, it 
is highly likely that the estimation of COVID-19’s impact would be 
confounded by these two well-established epidemics. The latter would 
have serious implications given the fact that SA has the highest burden 
of HIV in the world; there were 240 000 new HIV infections in 2018, 
and the country has experienced ~71 000 AIDS deaths annually.[8] 
Furthermore, there were 300 000 new TB infections in same year and 
63 000 TB-related deaths (two-thirds of these patients were living 
with HIV) annually, ~500 per 100 000 people.[9] The syndemic of 
HIV and TB potentiates risk during COVID-19 in two critical ways: 
potentially increasing severity of the clinical course for those with 
COVID-19, and also through advertent or inadvertent disruption of 
services for prevention and treatment programmes. Moreover, these 
disruptions may be associated with other competing health risks, 
including vaccinations, cancer screenings, non-communicable diseases 
and reproductive health programmes, during the COVID-19 crisis. [10,11] 
There may therefore be important and predictable short-, medium- 
and long-term implications associated with health system disruptions 
secondary to the COVID-19 crisis in SA.
The contextual factors described here suggest that the impacts of 
COVID-19 morbidity and mortality in SA may differ from those 
in other parts of the world. Taken together, these factors suggest 
the importance of integrating multiple SA-specific parameters in 
mathematical models that estimate COVID-19 impacts and in 
optimally scaling up COVID-19 prevention and mitigation strategies. 
Ultimately, appropriately parameterised mathematical models for 
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estimating the potential impact of COVID-19 in SA specifically 
are critical in informing contextually appropriate public health 
interventions, potential emergency and hospital care resources, 
policy, and governance.
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